Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

INFINITY™ With ADAPTIS™ Technology Study

NCT: NCT04594993 · ACTIVE_NOT_RECRUITING

NCT IDNCT04594993
StatusACTIVE_NOT_RECRUITING
Start Date2021-02-09
SponsorStryker Trauma and Extremities (INDUSTRY)
First posted
Last updated

Brief Summary

INFINITY™ with ADAPTIS™ Technology Total Ankle Replacement Follow-up (ITAR2) - Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 200 patients with up to 13 sites

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑